Modulation of eotaxin-3 (CCL26) in alveolar type II epithelial cells
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- State of the Art. Mechanistic Heterogeneity in Chronic Obstructive Pulmonary Disease: Insights from Transgenic MiceProceedings of the American Thoracic Society, 2006
- Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challengeJournal of Allergy and Clinical Immunology, 2005
- Cytokine-Stimulated Human Lung Alveolar Epithelial Cells Release Eotaxin-2 (CCL24) and Eotaxin-3 (CCL26)Journal of Interferon & Cytokine Research, 2005
- Chemokine receptor CCR5: insights into structure, function, and regulationCellular Signalling, 2004
- An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and EmphysemaPLOS Medicine, 2004
- Regulatory mechanisms of Th2 cytokine–induced eotaxin-3 production in bronchial epithelial cells: possible role of interleukin 4 receptor and nuclear factor–κBAnnals of Allergy, Asthma & Immunology, 2004
- Macrophage inflammatory protein-1The International Journal of Biochemistry & Cell Biology, 2004
- Asthma: Mechanisms of Disease Persistence and ProgressionAnnual Review of Immunology, 2004
- Chemokines inInnate andAdaptiveHostDefense: Basic Chemokinese Grammar for Immune CellsAnnual Review of Immunology, 2004